ATE12349T1 - Auf der niere aktive dipeptide. - Google Patents

Auf der niere aktive dipeptide.

Info

Publication number
ATE12349T1
ATE12349T1 AT82304702T AT82304702T ATE12349T1 AT E12349 T1 ATE12349 T1 AT E12349T1 AT 82304702 T AT82304702 T AT 82304702T AT 82304702 T AT82304702 T AT 82304702T AT E12349 T1 ATE12349 T1 AT E12349T1
Authority
AT
Austria
Prior art keywords
dipeptides
kidney
active
alpha
dimethoxyphenylalanyl
Prior art date
Application number
AT82304702T
Other languages
English (en)
Inventor
Francis Richard Pfeiffer
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Application granted granted Critical
Publication of ATE12349T1 publication Critical patent/ATE12349T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
AT82304702T 1981-09-09 1982-09-08 Auf der niere aktive dipeptide. ATE12349T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/300,546 US4395401A (en) 1981-09-09 1981-09-09 Renally active dipeptides
EP82304702A EP0074787B1 (de) 1981-09-09 1982-09-08 Auf der Niere aktive Dipeptide

Publications (1)

Publication Number Publication Date
ATE12349T1 true ATE12349T1 (de) 1985-04-15

Family

ID=23159558

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82304702T ATE12349T1 (de) 1981-09-09 1982-09-08 Auf der niere aktive dipeptide.

Country Status (10)

Country Link
US (1) US4395401A (de)
EP (1) EP0074787B1 (de)
JP (1) JPS5874649A (de)
AT (1) ATE12349T1 (de)
AU (1) AU549457B2 (de)
DE (1) DE3262800D1 (de)
DK (1) DK362082A (de)
GR (1) GR76703B (de)
IE (1) IE54226B1 (de)
ZA (1) ZA825331B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3226241A1 (de) * 1982-07-14 1984-01-26 Basf Ag, 6700 Ludwigshafen N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer
JPS62114957A (ja) * 1985-11-13 1987-05-26 Suntory Ltd プロリルエンドペプチダ−ゼ阻害作用を有する新規ピロリジン誘導体およびその製法並びに用途
FR2611205B1 (fr) * 1987-02-20 1990-03-02 Serbio Dipeptides, procede de preparation et utilisation dans le dosage de proteases
GB8929070D0 (en) * 1989-12-22 1990-02-28 Fujisawa Pharmaceutical Co Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
GB9023116D0 (en) * 1990-10-24 1990-12-05 Fujisawa Pharmaceutical Co Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
US6984627B1 (en) 1993-06-03 2006-01-10 Astrazeneca Ab Peptide derivatives
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US5783563A (en) * 1993-06-03 1998-07-21 Astra Aktiebolag Method for treatment or prophylaxis of venous thrombosis
GB9318637D0 (en) * 1993-09-08 1993-10-27 Ferring Res Ltd Enzyme inhibitors
RU2126418C1 (ru) * 1993-11-01 1999-02-20 Циба-Гейги Джапан Димитед Антагонисты рецепторов эндотелина
SE9404196D0 (sv) * 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
AR005245A1 (es) 1995-12-21 1999-04-28 Astrazeneca Ab Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
WO1998048826A1 (en) * 1997-04-30 1998-11-05 Northwestern University Inhibition of nitric oxide synthase by amino acids and dipeptides
AU759022B2 (en) * 1999-02-18 2003-04-03 Kaken Pharmaceutical Co., Ltd. Novel amide derivatives as growth hormone secretagogues

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2527932C2 (de) * 1974-07-02 1983-04-21 Pentapharm AG, 4052 Basel Säureadditionssalze von Tripeptidderivaten und deren Verwendung als Substrate zur Bestimmung von Plasmakallikrein

Also Published As

Publication number Publication date
DK362082A (da) 1983-03-10
EP0074787B1 (de) 1985-03-27
EP0074787A1 (de) 1983-03-23
ZA825331B (en) 1983-06-29
US4395401A (en) 1983-07-26
AU8645482A (en) 1983-03-17
AU549457B2 (en) 1986-01-30
IE54226B1 (en) 1989-07-19
JPS5874649A (ja) 1983-05-06
DE3262800D1 (en) 1985-05-02
GR76703B (de) 1984-08-29
IE822182L (en) 1983-03-09

Similar Documents

Publication Publication Date Title
ATE12349T1 (de) Auf der niere aktive dipeptide.
ATE12224T1 (de) Verbindungen mit antifibrinolytischer wirksamkeit.
DE3578258D1 (de) Stirnkontaktierung eines monolithischen kondensators.
ATE81858T1 (de) 6-thioxanthinderivate.
BE860764A (fr) Pompe d'aspiration tracheale
ES430370A1 (es) Un procedimiento para la preparacion de de-homoesteroides.
CA1269496C (en) MERCAPTOCYCLOALCOYLCARBONYL- AND MERCAPTOARYLCARBONYLDIPEPTIDES
ES515070A0 (es) "un conjunto de cuchilla distribuidora".
ES548330A0 (es) Un metodo de preparacion de un compuesto de tiadiazina
DE69006931T2 (de) Ghilanten: antimetastatischer Wirkstoff aus dem südamerikanischen Blutegel Haementeria Ghilianii.
GB1509454A (en) 2-amino-tetralins
IT7927041A0 (it) Procedimento per prevenire l'imbrattamento di elettrodi.
DE68908958T2 (de) Peptide.
IT1127048B (it) Perfezionamento nelle disposizioni di tenuta per pompe a depressione
GB1390650A (en) Oxazines and thiazines
SU567652A1 (ru) Всасывающее сопло пневмотранспортной установки
SU663347A1 (ru) Рабочий орган подборщика хлопка
IT7823549A0 (it) Composto di pentapeptide adattivita' analgesica.
SU741618A1 (ru) Центробежно-шестеренный насос
SU997415A1 (ru) Гидразоны 1,3-диметил-6-гидразиноурацила, проявляющие анальгетическую активность
GB1463261A (en) Dithia-tetraazacyclooctane-tetraoxide
DE3776981D1 (de) Druckablagerung von mesophasem pech.
SU738309A1 (ru) 2,4-Дибромфенилгидразиды дизамещенных гликолевых кислот, проявляющие анальгетическую активность
SU1319521A1 (ru) 5-(2,2,2-Трифтор-1-окси-1-трифторметилэтил)фурил-2-метилгидразонийбромид, проявляющий антимикробную и противовоспалительную активность
SU1297428A1 (ru) 54, 56:58, 60-дииндий (iii) дихлор-6, 11:19, 24:32, 37:45, 50-тетраимино-5-, 52:13, 18:20, 31:39, 44-тетранитрилоктабензо [с, д, е, р, и, у, d, h] (1, 10, 19, 28) - тетраазациклогексатриаконтин как полупроводник

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee